Portfolio of UPO Patents

https://www.uniupo.it/en/third-mission/technology-transfer/patents/portfolio-upo-patents

                                                                                                                                                     (Updated Dec, 17th, 2024)

Each patent is equipped with an in-depth chart, which indicates: the inventor(s), the relevant affiliations to the Departments, any co-ownership, the current status of the patent (geographical extension phase and/or existing agreements for use) and the link to the platform Knowledgeshare.

For any information or proposal, please refer to the email: tto@uniupo.it or to the number 0161-261520

 

Novel lentiviral vector particles
Process for the preparation of ceramides
  • L. Panza, D. Imperio, F. Albeverio, F. Carlomagno, A. Crimaldi, R. Malanchin
  • Co-ownership with Roelmi HPC S.r.l.
  • EPO patent application dated 16/02/2023
  • Ceramides, green process, sustainability, cosmesis, bio-cosmetics
  • Other links: https://www.roelmihpc.com/
Antibacterial agents, compositions and uses thereof
  • G.C. Tron, L. Fracchia, S. Aprile, F. brunelli, C. Ceresa
  • National Filing 02/08/2023; currently available
  • Antibacterial agents, infections, infectious diseases, gram-positive bacteria, Staphylococcus
  • Link KS: N.A.
RNA interference mediated therapy for neoplastic diseases
  • A. Sica, C. Porta, V. Garlatti, L. Carraro, S. Mola
  • Co-ownership with IRCCS Humanitas Mirasole S.p.A.
  • National Filing 29/06/2023; currently available
  • siRNA, TRIM28 protein, Cancer, Drug discovery and development
  • Link KS: N.A.
Inhibitors of Heme Oxygenase, compositions and uses thereof
  • A. Sica, G.C. Tron, F. Consonni
  • Co-ownership with IRCCS Humanitas Mirasole S.p.A.
  • National Filing 29/06/2023; currently available
  • Oncology, HO-1, Cancer, Drug discovery and development
  • Link KS: N.A.
     
Core-shell capsules of methacrylate or acrylate modified polysaccharides
  • L. Rimondini , A. Cochis , Loinaz Iraida , Gracia Raquel , Dupin Damien
  • Co-ownership with CIDETEC
  • EPO patent application EP22383250
  • Tissue engineering, chondral repair, nanobiomaterials 3D
  • Link KS: n.a.

Other links: http://restoreproject.eu/

Ligands and Fe(III) complexes thereof for MRI
  • M. Botta , L. Tei , F. Carniato , Boccalon M. , Baranyai Z.
  • Co-ownership with S.p.A.
  • EPO patent application EP22187403
  • Imaging, Diagnostics, Biocompatibility
  • Link KS: n.a.

Other links: https://www.bracco.com/

Probe directed to enzyme aldh1a3 and use thereof in the diagnosis of glioblastoma
  • S. Garavaglia, M. Rizzi, A. Minassi, D. Caprioglio, E. Gelardi, G. Colombo, L. Magrassi
  • Co-ownership with Università di Pavia
  • National Filing 6/4/2021; PCT extension. Currently available
  • Other links: NA
SIRT1 Inhibitor or antagonist for use in preventing and/or treating an hpv induced disease
Biphenyl compounds as SOCE modulators, compositions and related uses
Rigidified pentadentate chelating agents useful for the [Al18F]2+ labelling of biomolecules
New therapeutic anticancer agents
Endothelial-Specific promoter sequences and uses therfore
Promoter for cell-specific gene expression and use thereof
Method for inducing and differentiating pluripotent stem cells
SOCE modulators, compositions and related uses
Use of mesoporous silica
B7h Receptor Ligands in the Treatment of Osteopenia and Osteoporosis